Outlook Therapeutics (OTLK) announced that it has commenced a best-efforts public offering of its common stock and accompanying warrants exercisable for shares of its common stock. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics Refinances Debt, Extends Note Maturities
- Outlook Therapeutics announces $18.4M non-convertible note financing
- Outlook Therapeutics Announces Board Resignation and Size Reduction
- Outlook Therapeutics price target lowered to $6 from $10 at Ascendiant
- Outlook Therapeutics Shareholders Back Board, Pay, and Auditor